The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global OTC Pet Medication Market 2024 by Company, Regions, Type and Application, Forecast to 2028
Synopsis
The OTC Pet Medication market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global OTC Pet Medication market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Dogs & Cats accounting for % of the OTC Pet Medication global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Fleas & Ticks Removal segment is altered to a % CAGR between 2022 and 2028.
Global key companies of OTC Pet Medication include Bayer Companion Animal, Boehringer Ingelheim Animal Health, Ceva Sante Animale, Merck Inc., and Zoetis Inc., etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
OTC Pet Medication market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Fleas & Ticks Removal
Pain Relief & Arthritis
Dewormers
Others
Market segment by Application, can be divided into
Dogs & Cats
Birds
Fish & Reptiles
Others
Market segment by players, this report covers
Bayer Companion Animal
Boehringer Ingelheim Animal Health
Ceva Sante Animale
Merck Inc.
Zoetis Inc.
Elanco
Virbac SA
Vetoquinol SA
Frontline
Zymox
ChloraSeb
Sulfox
Adequan
Dechra Pharmaceuticals PLC
Nutramax Laboratories, Inc.
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe OTC Pet Medication product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of OTC Pet Medication, with revenue, gross margin and global market share of OTC Pet Medication from 2019 to 2022.
Chapter 3, the OTC Pet Medication competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and OTC Pet Medication market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe OTC Pet Medication research findings and conclusion, appendix and data source.
Geographical Area
Global
The OTC Pet Medication market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global OTC Pet Medication market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Dogs & Cats accounting for % of the OTC Pet Medication global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Fleas & Ticks Removal segment is altered to a % CAGR between 2022 and 2028.
Global key companies of OTC Pet Medication include Bayer Companion Animal, Boehringer Ingelheim Animal Health, Ceva Sante Animale, Merck Inc., and Zoetis Inc., etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
OTC Pet Medication market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Fleas & Ticks Removal
Pain Relief & Arthritis
Dewormers
Others
Market segment by Application, can be divided into
Dogs & Cats
Birds
Fish & Reptiles
Others
Market segment by players, this report covers
Bayer Companion Animal
Boehringer Ingelheim Animal Health
Ceva Sante Animale
Merck Inc.
Zoetis Inc.
Elanco
Virbac SA
Vetoquinol SA
Frontline
Zymox
ChloraSeb
Sulfox
Adequan
Dechra Pharmaceuticals PLC
Nutramax Laboratories, Inc.
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe OTC Pet Medication product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of OTC Pet Medication, with revenue, gross margin and global market share of OTC Pet Medication from 2019 to 2022.
Chapter 3, the OTC Pet Medication competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and OTC Pet Medication market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe OTC Pet Medication research findings and conclusion, appendix and data source.
Geographical Area
Global
Index1 Market Overview
1.1 Product Overview and Scope of OTC Pet Medication
1.2 Classification of OTC Pet Medication by Type
1.2.1 Overview: Global OTC Pet Medication Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global OTC Pet Medication Revenue Market Share by Type in 2021
1.2.3 Fleas & Ticks Removal
1.2.4 Pain Relief & Arthritis
1.2.5 Dewormers
1.2.6 Others
1.3 Global OTC Pet Medication Market by Application
1.3.1 Overview: Global OTC Pet Medication Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Dogs & Cats
1.3.3 Birds
1.3.4 Fish & Reptiles
1.3.5 Others
1.4 Global OTC Pet Medication Market Size & Forecast
1.5 Global OTC Pet Medication Market Size and Forecast by Region
1.5.1 Global OTC Pet Medication Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global OTC Pet Medication Market Size by Region, (2017-2022)
1.5.3 North America OTC Pet Medication Market Size and Prospect (2017-2028)
1.5.4 Europe OTC Pet Medication Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific OTC Pet Medication Market Size and Prospect (2017-2028)
1.5.6 South America OTC Pet Medication Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa OTC Pet Medication Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 OTC Pet Medication Market Drivers
1.6.2 OTC Pet Medication Market Restraints
1.6.3 OTC Pet Medication Trends Analysis
2 Company Profiles
2.1 Bayer Companion Animal
2.1.1 Bayer Companion Animal Details
2.1.2 Bayer Companion Animal Major Business
2.1.3 Bayer Companion Animal OTC Pet Medication Product and Solutions
2.1.4 Bayer Companion Animal OTC Pet Medication Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Bayer Companion Animal Recent Developments and Future Plans
2.2 Boehringer Ingelheim Animal Health
2.2.1 Boehringer Ingelheim Animal Health Details
2.2.2 Boehringer Ingelheim Animal Health Major Business
2.2.3 Boehringer Ingelheim Animal Health OTC Pet Medication Product and Solutions
2.2.4 Boehringer Ingelheim Animal Health OTC Pet Medication Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Boehringer Ingelheim Animal Health Recent Developments and Future Plans
2.3 Ceva Sante Animale
2.3.1 Ceva Sante Animale Details
2.3.2 Ceva Sante Animale Major Business
2.3.3 Ceva Sante Animale OTC Pet Medication Product and Solutions
2.3.4 Ceva Sante Animale OTC Pet Medication Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Ceva Sante Animale Recent Developments and Future Plans
2.4 Merck Inc.
2.4.1 Merck Inc. Details
2.4.2 Merck Inc. Major Business
2.4.3 Merck Inc. OTC Pet Medication Product and Solutions
2.4.4 Merck Inc. OTC Pet Medication Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Merck Inc. Recent Developments and Future Plans
2.5 Zoetis Inc.
2.5.1 Zoetis Inc. Details
2.5.2 Zoetis Inc. Major Business
2.5.3 Zoetis Inc. OTC Pet Medication Product and Solutions
2.5.4 Zoetis Inc. OTC Pet Medication Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Zoetis Inc. Recent Developments and Future Plans
2.6 Elanco
2.6.1 Elanco Details
2.6.2 Elanco Major Business
2.6.3 Elanco OTC Pet Medication Product and Solutions
2.6.4 Elanco OTC Pet Medication Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Elanco Recent Developments and Future Plans
2.7 Virbac SA
2.7.1 Virbac SA Details
2.7.2 Virbac SA Major Business
2.7.3 Virbac SA OTC Pet Medication Product and Solutions
2.7.4 Virbac SA OTC Pet Medication Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Virbac SA Recent Developments and Future Plans
2.8 Vetoquinol SA
2.8.1 Vetoquinol SA Details
2.8.2 Vetoquinol SA Major Business
2.8.3 Vetoquinol SA OTC Pet Medication Product and Solutions
2.8.4 Vetoquinol SA OTC Pet Medication Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Vetoquinol SA Recent Developments and Future Plans
2.9 Frontline
2.9.1 Frontline Details
2.9.2 Frontline Major Business
2.9.3 Frontline OTC Pet Medication Product and Solutions
2.9.4 Frontline OTC Pet Medication Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Frontline Recent Developments and Future Plans
2.10 Zymox
2.10.1 Zymox Details
2.10.2 Zymox Major Business
2.10.3 Zymox OTC Pet Medication Product and Solutions
2.10.4 Zymox OTC Pet Medication Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 Zymox Recent Developments and Future Plans
2.11 ChloraSeb
2.11.1 ChloraSeb Details
2.11.2 ChloraSeb Major Business
2.11.3 ChloraSeb OTC Pet Medication Product and Solutions
2.11.4 ChloraSeb OTC Pet Medication Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 ChloraSeb Recent Developments and Future Plans
2.12 Sulfox
2.12.1 Sulfox Details
2.12.2 Sulfox Major Business
2.12.3 Sulfox OTC Pet Medication Product and Solutions
2.12.4 Sulfox OTC Pet Medication Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12.5 Sulfox Recent Developments and Future Plans
2.13 Adequan
2.13.1 Adequan Details
2.13.2 Adequan Major Business
2.13.3 Adequan OTC Pet Medication Product and Solutions
2.13.4 Adequan OTC Pet Medication Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13.5 Adequan Recent Developments and Future Plans
2.14 Dechra Pharmaceuticals PLC
2.14.1 Dechra Pharmaceuticals PLC Details
2.14.2 Dechra Pharmaceuticals PLC Major Business
2.14.3 Dechra Pharmaceuticals PLC OTC Pet Medication Product and Solutions
2.14.4 Dechra Pharmaceuticals PLC OTC Pet Medication Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14.5 Dechra Pharmaceuticals PLC Recent Developments and Future Plans
2.15 Nutramax Laboratories, Inc.
2.15.1 Nutramax Laboratories, Inc. Details
2.15.2 Nutramax Laboratories, Inc. Major Business
2.15.3 Nutramax Laboratories, Inc. OTC Pet Medication Product and Solutions
2.15.4 Nutramax Laboratories, Inc. OTC Pet Medication Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15.5 Nutramax Laboratories, Inc. Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global OTC Pet Medication Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 OTC Pet Medication Players Market Share in 2021
3.2.2 Top 10 OTC Pet Medication Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 OTC Pet Medication Players Head Office, Products and Services Provided
3.4 OTC Pet Medication Mergers & Acquisitions
3.5 OTC Pet Medication New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global OTC Pet Medication Revenue and Market Share by Type (2017-2022)
4.2 Global OTC Pet Medication Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5.1 Global OTC Pet Medication Revenue Market Share by Application (2017-2022)
5.2 Global OTC Pet Medication Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6.1 North America OTC Pet Medication Revenue by Type (2017-2028)
6.2 North America OTC Pet Medication Revenue by Application (2017-2028)
6.3 North America OTC Pet Medication Market Size by Country
6.3.1 North America OTC Pet Medication Revenue by Country (2017-2028)
6.3.2 United States OTC Pet Medication Market Size and Forecast (2017-2028)
6.3.3 Canada OTC Pet Medication Market Size and Forecast (2017-2028)
6.3.4 Mexico OTC Pet Medication Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7.1 Europe OTC Pet Medication Revenue by Type (2017-2028)
7.2 Europe OTC Pet Medication Revenue by Application (2017-2028)
7.3 Europe OTC Pet Medication Market Size by Country
7.3.1 Europe OTC Pet Medication Revenue by Country (2017-2028)
7.3.2 Germany OTC Pet Medication Market Size and Forecast (2017-2028)
7.3.3 France OTC Pet Medication Market Size and Forecast (2017-2028)
7.3.4 United Kingdom OTC Pet Medication Market Size and Forecast (2017-2028)
7.3.5 Russia OTC Pet Medication Market Size and Forecast (2017-2028)
7.3.6 Italy OTC Pet Medication Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific OTC Pet Medication Revenue by Type (2017-2028)
8.2 Asia-Pacific OTC Pet Medication Revenue by Application (2017-2028)
8.3 Asia-Pacific OTC Pet Medication Market Size by Region
8.3.1 Asia-Pacific OTC Pet Medication Revenue by Region (2017-2028)
8.3.2 China OTC Pet Medication Market Size and Forecast (2017-2028)
8.3.3 Japan OTC Pet Medication Market Size and Forecast (2017-2028)
8.3.4 South Korea OTC Pet Medication Market Size and Forecast (2017-2028)
8.3.5 India OTC Pet Medication Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia OTC Pet Medication Market Size and Forecast (2017-2028)
8.3.7 Australia OTC Pet Medication Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9.1 South America OTC Pet Medication Revenue by Type (2017-2028)
9.2 South America OTC Pet Medication Revenue by Application (2017-2028)
9.3 South America OTC Pet Medication Market Size by Country
9.3.1 South America OTC Pet Medication Revenue by Country (2017-2028)
9.3.2 Brazil OTC Pet Medication Market Size and Forecast (2017-2028)
9.3.3 Argentina OTC Pet Medication Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa OTC Pet Medication Revenue by Type (2017-2028)
10.2 Middle East & Africa OTC Pet Medication Revenue by Application (2017-2028)
10.3 Middle East & Africa OTC Pet Medication Market Size by Country
10.3.1 Middle East & Africa OTC Pet Medication Revenue by Country (2017-2028)
10.3.2 Turkey OTC Pet Medication Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia OTC Pet Medication Market Size and Forecast (2017-2028)
10.3.4 UAE OTC Pet Medication Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of TablesList of Tables
Table 1. Global OTC Pet Medication Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global OTC Pet Medication Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market OTC Pet Medication Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global OTC Pet Medication Revenue (USD Million) by Region (2017-2022)
Table 5. Global OTC Pet Medication Revenue Market Share by Region (2023-2028)
Table 6. Bayer Companion Animal Corporate Information, Head Office, and Major Competitors
Table 7. Bayer Companion Animal Major Business
Table 8. Bayer Companion Animal OTC Pet Medication Product and Solutions
Table 9. Bayer Companion Animal OTC Pet Medication Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Boehringer Ingelheim Animal Health Corporate Information, Head Office, and Major Competitors
Table 11. Boehringer Ingelheim Animal Health Major Business
Table 12. Boehringer Ingelheim Animal Health OTC Pet Medication Product and Solutions
Table 13. Boehringer Ingelheim Animal Health OTC Pet Medication Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Ceva Sante Animale Corporate Information, Head Office, and Major Competitors
Table 15. Ceva Sante Animale Major Business
Table 16. Ceva Sante Animale OTC Pet Medication Product and Solutions
Table 17. Ceva Sante Animale OTC Pet Medication Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Merck Inc. Corporate Information, Head Office, and Major Competitors
Table 19. Merck Inc. Major Business
Table 20. Merck Inc. OTC Pet Medication Product and Solutions
Table 21. Merck Inc. OTC Pet Medication Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Zoetis Inc. Corporate Information, Head Office, and Major Competitors
Table 23. Zoetis Inc. Major Business
Table 24. Zoetis Inc. OTC Pet Medication Product and Solutions
Table 25. Zoetis Inc. OTC Pet Medication Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Elanco Corporate Information, Head Office, and Major Competitors
Table 27. Elanco Major Business
Table 28. Elanco OTC Pet Medication Product and Solutions
Table 29. Elanco OTC Pet Medication Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Virbac SA Corporate Information, Head Office, and Major Competitors
Table 31. Virbac SA Major Business
Table 32. Virbac SA OTC Pet Medication Product and Solutions
Table 33. Virbac SA OTC Pet Medication Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Vetoquinol SA Corporate Information, Head Office, and Major Competitors
Table 35. Vetoquinol SA Major Business
Table 36. Vetoquinol SA OTC Pet Medication Product and Solutions
Table 37. Vetoquinol SA OTC Pet Medication Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Frontline Corporate Information, Head Office, and Major Competitors
Table 39. Frontline Major Business
Table 40. Frontline OTC Pet Medication Product and Solutions
Table 41. Frontline OTC Pet Medication Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Zymox Corporate Information, Head Office, and Major Competitors
Table 43. Zymox Major Business
Table 44. Zymox OTC Pet Medication Product and Solutions
Table 45. Zymox OTC Pet Medication Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. ChloraSeb Corporate Information, Head Office, and Major Competitors
Table 47. ChloraSeb Major Business
Table 48. ChloraSeb OTC Pet Medication Product and Solutions
Table 49. ChloraSeb OTC Pet Medication Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. Sulfox Corporate Information, Head Office, and Major Competitors
Table 51. Sulfox Major Business
Table 52. Sulfox OTC Pet Medication Product and Solutions
Table 53. Sulfox OTC Pet Medication Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 54. Adequan Corporate Information, Head Office, and Major Competitors
Table 55. Adequan Major Business
Table 56. Adequan OTC Pet Medication Product and Solutions
Table 57. Adequan OTC Pet Medication Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 58. Dechra Pharmaceuticals PLC Corporate Information, Head Office, and Major Competitors
Table 59. Dechra Pharmaceuticals PLC Major Business
Table 60. Dechra Pharmaceuticals PLC OTC Pet Medication Product and Solutions
Table 61. Dechra Pharmaceuticals PLC OTC Pet Medication Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 62. Nutramax Laboratories, Inc. Corporate Information, Head Office, and Major Competitors
Table 63. Nutramax Laboratories, Inc. Major Business
Table 64. Nutramax Laboratories, Inc. OTC Pet Medication Product and Solutions
Table 65. Nutramax Laboratories, Inc. OTC Pet Medication Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 66. Global OTC Pet Medication Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 67. Global OTC Pet Medication Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 68. Breakdown of OTC Pet Medication by Company Type (Tier 1, Tier 2 and Tier 3)
Table 69. OTC Pet Medication Players Head Office, Products and Services Provided
Table 70. OTC Pet Medication Mergers & Acquisitions in the Past Five Years
Table 71. OTC Pet Medication New Entrants and Expansion Plans
Table 72. Global OTC Pet Medication Revenue (USD Million) by Type (2017-2022)
Table 73. Global OTC Pet Medication Revenue Share by Type (2017-2022)
Table 74. Global OTC Pet Medication Revenue Forecast by Type (2023-2028)
Table 75. Global OTC Pet Medication Revenue by Application (2017-2022)
Table 76. Global OTC Pet Medication Revenue Forecast by Application (2023-2028)
Table 77. North America OTC Pet Medication Revenue by Type (2017-2022) & (USD Million)
Table 78. North America OTC Pet Medication Revenue by Type (2023-2028) & (USD Million)
Table 79. North America OTC Pet Medication Revenue by Application (2017-2022) & (USD Million)
Table 80. North America OTC Pet Medication Revenue by Application (2023-2028) & (USD Million)
Table 81. North America OTC Pet Medication Revenue by Country (2017-2022) & (USD Million)
Table 82. North America OTC Pet Medication Revenue by Country (2023-2028) & (USD Million)
Table 83. Europe OTC Pet Medication Revenue by Type (2017-2022) & (USD Million)
Table 84. Europe OTC Pet Medication Revenue by Type (2023-2028) & (USD Million)
Table 85. Europe OTC Pet Medication Revenue by Application (2017-2022) & (USD Million)
Table 86. Europe OTC Pet Medication Revenue by Application (2023-2028) & (USD Million)
Table 87. Europe OTC Pet Medication Revenue by Country (2017-2022) & (USD Million)
Table 88. Europe OTC Pet Medication Revenue by Country (2023-2028) & (USD Million)
Table 89. Asia-Pacific OTC Pet Medication Revenue by Type (2017-2022) & (USD Million)
Table 90. Asia-Pacific OTC Pet Medication Revenue by Type (2023-2028) & (USD Million)
Table 91. Asia-Pacific OTC Pet Medication Revenue by Application (2017-2022) & (USD Million)
Table 92. Asia-Pacific OTC Pet Medication Revenue by Application (2023-2028) & (USD Million)
Table 93. Asia-Pacific OTC Pet Medication Revenue by Region (2017-2022) & (USD Million)
Table 94. Asia-Pacific OTC Pet Medication Revenue by Region (2023-2028) & (USD Million)
Table 95. South America OTC Pet Medication Revenue by Type (2017-2022) & (USD Million)
Table 96. South America OTC Pet Medication Revenue by Type (2023-2028) & (USD Million)
Table 97. South America OTC Pet Medication Revenue by Application (2017-2022) & (USD Million)
Table 98. South America OTC Pet Medication Revenue by Application (2023-2028) & (USD Million)
Table 99. South America OTC Pet Medication Revenue by Country (2017-2022) & (USD Million)
Table 100. South America OTC Pet Medication Revenue by Country (2023-2028) & (USD Million)
Table 101. Middle East & Africa OTC Pet Medication Revenue by Type (2017-2022) & (USD Million)
Table 102. Middle East & Africa OTC Pet Medication Revenue by Type (2023-2028) & (USD Million)
Table 103. Middle East & Africa OTC Pet Medication Revenue by Application (2017-2022) & (USD Million)
Table 104. Middle East & Africa OTC Pet Medication Revenue by Application (2023-2028) & (USD Million)
Table 105. Middle East & Africa OTC Pet Medication Revenue by Country (2017-2022) & (USD Million)
Table 106. Middle East & Africa OTC Pet Medication Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. OTC Pet Medication Picture
Figure 2. Global OTC Pet Medication Revenue Market Share by Type in 2021
Figure 3. Fleas & Ticks Removal
Figure 4. Pain Relief & Arthritis
Figure 5. Dewormers
Figure 6. Others
Figure 7. OTC Pet Medication Revenue Market Share by Application in 2021
Figure 8. Dogs & Cats Picture
Figure 9. Birds Picture
Figure 10. Fish & Reptiles Picture
Figure 11. Others Picture
Figure 12. Global OTC Pet Medication Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 13. Global OTC Pet Medication Revenue and Forecast (2017-2028) & (USD Million)
Figure 14. Global OTC Pet Medication Revenue Market Share by Region (2017-2028)
Figure 15. Global OTC Pet Medication Revenue Market Share by Region in 2021
Figure 16. North America OTC Pet Medication Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. Europe OTC Pet Medication Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. Asia-Pacific OTC Pet Medication Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. South America OTC Pet Medication Revenue (USD Million) and Growth Rate (2017-2028)
Figure 20. Middle East and Africa OTC Pet Medication Revenue (USD Million) and Growth Rate (2017-2028)
Figure 21. OTC Pet Medication Market Drivers
Figure 22. OTC Pet Medication Market Restraints
Figure 23. OTC Pet Medication Market Trends
Figure 24. Bayer Companion Animal Recent Developments and Future Plans
Figure 25. Boehringer Ingelheim Animal Health Recent Developments and Future Plans
Figure 26. Ceva Sante Animale Recent Developments and Future Plans
Figure 27. Merck Inc. Recent Developments and Future Plans
Figure 28. Zoetis Inc. Recent Developments and Future Plans
Figure 29. Elanco Recent Developments and Future Plans
Figure 30. Virbac SA Recent Developments and Future Plans
Figure 31. Vetoquinol SA Recent Developments and Future Plans
Figure 32. Frontline Recent Developments and Future Plans
Figure 33. Zymox Recent Developments and Future Plans
Figure 34. ChloraSeb Recent Developments and Future Plans
Figure 35. Sulfox Recent Developments and Future Plans
Figure 36. Adequan Recent Developments and Future Plans
Figure 37. Dechra Pharmaceuticals PLC Recent Developments and Future Plans
Figure 38. Nutramax Laboratories, Inc. Recent Developments and Future Plans
Figure 39. Global OTC Pet Medication Revenue Share by Players in 2021
Figure 40. OTC Pet Medication Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 41. Global Top 3 Players OTC Pet Medication Revenue Market Share in 2021
Figure 42. Global Top 10 Players OTC Pet Medication Revenue Market Share in 2021
Figure 43. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 44. Global OTC Pet Medication Revenue Share by Type in 2021
Figure 45. Global OTC Pet Medication Market Share Forecast by Type (2023-2028)
Figure 46. Global OTC Pet Medication Revenue Share by Application in 2021
Figure 47. Global OTC Pet Medication Market Share Forecast by Application (2023-2028)
Figure 48. North America OTC Pet Medication Sales Market Share by Type (2017-2028)
Figure 49. North America OTC Pet Medication Sales Market Share by Application (2017-2028)
Figure 50. North America OTC Pet Medication Revenue Market Share by Country (2017-2028)
Figure 51. United States OTC Pet Medication Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Canada OTC Pet Medication Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Mexico OTC Pet Medication Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Europe OTC Pet Medication Sales Market Share by Type (2017-2028)
Figure 55. Europe OTC Pet Medication Sales Market Share by Application (2017-2028)
Figure 56. Europe OTC Pet Medication Revenue Market Share by Country (2017-2028)
Figure 57. Germany OTC Pet Medication Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. France OTC Pet Medication Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. United Kingdom OTC Pet Medication Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Russia OTC Pet Medication Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Italy OTC Pet Medication Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Asia-Pacific OTC Pet Medication Sales Market Share by Type (2017-2028)
Figure 63. Asia-Pacific OTC Pet Medication Sales Market Share by Application (2017-2028)
Figure 64. Asia-Pacific OTC Pet Medication Revenue Market Share by Region (2017-2028)
Figure 65. China OTC Pet Medication Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Japan OTC Pet Medication Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. South Korea OTC Pet Medication Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. India OTC Pet Medication Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Southeast Asia OTC Pet Medication Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Australia OTC Pet Medication Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. South America OTC Pet Medication Sales Market Share by Type (2017-2028)
Figure 72. South America OTC Pet Medication Sales Market Share by Application (2017-2028)
Figure 73. South America OTC Pet Medication Revenue Market Share by Country (2017-2028)
Figure 74. Brazil OTC Pet Medication Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Argentina OTC Pet Medication Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Middle East and Africa OTC Pet Medication Sales Market Share by Type (2017-2028)
Figure 77. Middle East and Africa OTC Pet Medication Sales Market Share by Application (2017-2028)
Figure 78. Middle East and Africa OTC Pet Medication Revenue Market Share by Country (2017-2028)
Figure 79. Turkey OTC Pet Medication Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 80. Saudi Arabia OTC Pet Medication Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 81. UAE OTC Pet Medication Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 82. Methodology
Figure 83. Research Process and Data Source
Published By : GlobalInfoResearch
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
